Uncomplicated Pregnancy in IBD
Activity: Uncomplicated Pregnancy in Inflammatory Bowel Disease
|
Estimated time to complete:
1 hour
|
To contact the accreditor:
Visit www.pimed.com
Or e-mail [email protected]
|
Jointly provided by:
Crohn's & Colitis Foundation
Postgraduate Institute for Medicine
|
Release date: January 20, 2020 |
Expiration date: This activity expired for CME credit and the content is available for viewing purposes only. |
Audience
This activity is for intended physician assistants, nurse practitioners, and nurses engaged in the care of patients with inflammatory bowel diseases.
Faculty
|
Elena Fisher, FNP-BC, MS, RN
Gastroenterology Nurse Practitioner
Department of Veterans Affairs
New Mexico VA Healthcare System
|
Educational Objectives
After completing this activity, the participant should be better able to:
-
Discuss preconception planning with an IBD patient
-
Assess the impact of various IBD treatments during pregnancy
-
Describe monitoring strategies during a normal pregnancy to ensure a safe pregnancy and delivery
-
Joint Accreditation Statement
-
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and the Crohn’s & Colitis Foundation. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
-
Physician Continuing Medical Education
-
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
-
Continuing Nursing Education
-
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.
-
Disclosure of Conflicts of Interest
-
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
FACULTY: Elena R. Fisher FNP-BC, MS, RN has nothing to disclose
PLANNERS AND MANAGERS: The PIM planners and managers have nothing to disclose. The Crohn’s & Colitis Foundation planners and managers have nothing to disclose.
-
Method of Participation and Request for Credit
-
There are no fees for participating and receiving CME/CE credit for this activity. During the period of March 9, 2021 through March 9, 2022, participants must read the learning objectives and faculty disclosures and study the educational activity.
If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 14880. Upon registering and successfully completing the post-test with a score of 75% or better and the activity evaluation, your certificate will be made available immediately.
-
Media & Computer Requirements
-
This activity requires internet and is recommended for desktop.
-
Disclosure of Unlabeled Use
-
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
-
Disclaimer
-
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.